Multiple Sclerosis in a Patient with Intermediate Uveitis and Juvenile Idiopathic Arthritis Treated with Adalimumab: A Case Report

William Rojas-Carabali, Laura Boada-Robayo, Daniela Chacón-Zambrano, Eveling Criollo Porras, Valentina Kerguelén Dumar, Alejandra de-la-Torre

Research output: Contribution to journalResearch Articlepeer-review

1 Scopus citations

Abstract

Purpose: To report a case of multiple sclerosis (MS) development in a patient with Juvenile Idiopathic Arthritis (JIA) and bilateral intermediate uveitis (IU) treated with Adalimumab. Case report: A 21-year-old Colombian woman diagnosed with JIA and bilateral refractory IU treated with methotrexate and Adalimumab with difficult control of the disease and multiple ocular complications. Eight years after starting Adalimumab, the patient presented paresthesia in the left upper limb. Radiologic findings in the brain and cervical spine MRI confirmed the diagnosis of MS. Conclusions: We reported the first case of MS development in a patient with JIA treated with Adalimumab and the third in a patient with noninfectious uveitis treated with anti-TNFα. It remains uncertain whether MS is secondary to anti-TNFα therapy or is linked to a polyautoimmunity phenomenon.

Translated title of the contributionEsclerosis múltiple en un paciente con uveítis intermedia y artritis idiopática juvenil tratado con adalimumab: reporte de un caso
Original languageEnglish (US)
Pages (from-to)1-4
Number of pages4
JournalOcular Immunology and Inflammation
DOIs
StatePublished - Sep 23 2022

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Ophthalmology

Fingerprint

Dive into the research topics of 'Multiple Sclerosis in a Patient with Intermediate Uveitis and Juvenile Idiopathic Arthritis Treated with Adalimumab: A Case Report'. Together they form a unique fingerprint.

Cite this